Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0QLQ stock hub

LON/0QLQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QLQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

3.7B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QLQ

In the news

Latest news · LON/0QLQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E23

P25 12.9P50 16.9P75 23.5

Trailing P/E20.6

P25 15.9P50 22.9P75 35.8

ROE27.2

P25 -54.2P50 2.1P75 13.7

ROIC27.6

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QLQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

CHF

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Switzerland
Country code	UK
Employees	2,000
Employees Change	-644%
Employees Change Percent	-24.36
Enterprise value	CHF 3.7B
Exchange	London Stock Exchange
Financial currency	CHF
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	CH0019396990
Last refreshed	2026-05-10
Market cap	CHF 3.7B
Price	CHF 290
Price currency	CHF
Rev Per Employee	367,383.93x
Sector	Healthcare
Sic	3842
Symbol	lon/0QLQ
Website	https://www.ypsomed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.87%
EV Earnings	20.41x
EV/EBIT	16.34x
EV/EBITDA	13.37x
EV/FCF	-182.53x
EV/Sales	4.97x
FCF yield	-0.54%
Forward P/E	22.99x
P/B ratio	4.94x
P/E ratio	20.55x
P/S ratio	5.06x
PE Ratio10 Y	104.42x
PE Ratio3 Y	53.15x
PE Ratio5 Y	54.7x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	30.42%
EBITDA Margin	37.19%
Gross margin	39.29%
Gross Profit	CHF 288.7M
Gross Profit Growth	5.95%
Gross Profit Growth Q	13.1%
Gross Profit Growth3 Y	12.12%
Gross Profit Growth5 Y	17.09%
Net Income	CHF 181M
Net Income Growth	160.8%
Net Income Growth Q	326.67%
Net Income Growth Quarters	3%
Net Income Growth Years	4%
Net Income Growth3 Y	35.28%
Net Income Growth5 Y	30.49%
Pretax Margin	27.34%
Profit Margin	24.63%
Profit Per Employee	CHF 90,498
Profitable Years	24
ROA	12.53
Roa5y	3.69
ROCE	25.03
ROE	27.15
Roe5y	8.98
ROIC	27.65
Roic5y	6.95

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-16.82%
Cagr3y	10.95%
Cagr5y	14.88%
Div CAGR10	9.96%
Div CAGR3	22.1%
Div CAGR5	17.45%
EPS Growth	160.7
EPS Growth Q	326.7
EPS Growth Quarters	3
EPS Growth Years	4
EPS Growth3 Y	35.28
EPS Growth5 Y	30.05
OCF Growth	35.1%
OCF Growth Q	94.9%
OCF Growth10 Y	14.55%
OCF Growth3 Y	9.05%
OCF Growth5 Y	10.32%
Revenue Growth	27.63x
Revenue Growth Q	11.94x
Revenue Growth Quarters	3x
Revenue Growth Years	5x
Revenue Growth3 Y	12.82x
Revenue Growth5 Y	9.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CHF 0.66
Assets	CHF 1.1B
Cash	CHF 33.9M
Current Assets	CHF 349.3M
Current Liabilities	CHF 237.6M
Debt	CHF 9.3M
Debt EBITDA	CHF 0.03
Debt Equity	CHF 0.01
Debt FCF	CHF -0.46
Equity	CHF 753.1M
Interest Coverage	43.27
Liabilities	CHF 374.6M
Long Term Assets	CHF 778.4M
Long Term Liabilities	CHF 137M
Net Cash	CHF 24.5M
Net Cash By Market Cap	CHF 0.66
Net Debt EBITDA	CHF -0.09
Net Debt Equity	CHF -0.03
Tangible Book Value	CHF 608.3M
Tangible Book Value Per Share	CHF 44.58
WACC	8.52

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.47
Inventory Turnover	6.34
Net Working Capital	CHF 85.8M
Quick ratio	0.75
Working Capital	CHF 110.4M
Working Capital Turnover	CHF -27.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0%
Dividend Growth	16.13%
Dividend Growth Years	3%
Dividend per share	CHF 2.03
Dividend Years	13
Dividend Yield	0.72%
Ex Div Date	2025-07-04
Last Dividend	CHF 2.03
Payout Frequency	Annual
Payout Ratio	15.47%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-16.81%
200-day SMA	329
3Y total return	36.57%
50-day SMA	282
50-day SMA vs 200-day SMA	50under200
5Y total return	100.09%
All Time High	440
All Time High Change	-34.36%
All Time High Date	2025-07-28
All Time Low	103.4
All Time Low Change	179.3%
All Time Low Date	2020-03-16
ATR	8.37
Beta	0.74
Ch YTD	-11.45
High	298.6
High52	440
High52 Date	2025-07-28
High52ch	-34.17%
Low	288.6
Low52	263.5
Low52 Date	2026-03-02
Low52ch	9.92%
Ma50ch	2.43%
Price vs 200-day SMA	-12.21%
RSI	54.53
RSI Monthly	44.35
RSI Weekly	42.95
Sharpe ratio	-0.73x
Sortino ratio	-0.78
Total Return	0.73%
Tr YTD	-11.45
Tr1m	6.57%
Tr1w	2.52%
Tr3m	-0.23%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CHF 223.5M
Operating Income Growth	94.64
Operating Income Growth Q	229.6
Operating Income Growth3 Y	40.59
Operating Income Growth5 Y	40.8
Operating margin	30.42

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4,007,431%
Net Borrowing	-202,978,949.9
Shares Insiders	70.56%
Shares Institutions	10.83%
Shares Qo Q	0%
Shares Yo Y	-0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CHF -20.2M
Average Volume	1,607.8x
Bv Per Share	55.19
CAPEX	CHF -217.7M
Ch1m	6.57
Ch1w	2.52
Ch1y	-17.25
Ch3m	-0.23
Ch3y	34.55
Ch5y	94.11
Ch6m	-6.4
Change	-2.33%
Change From Open	-2.35
Close	296.5
Days Gap	0.02
Depreciation Amortization	50,334,059.1
Dollar Volume	392,168.1
Earnings Date	2026-05-20
EBIT	CHF 223.5M
EBITDA	CHF 273.3M
EPS	CHF 13.26
F Score	7
FCF	CHF -20.2M
FCF EV Yield	-0.55x
Financing CF	-230,125,241
Fiscal Year End	March
Founded	1,984
Graham Number	135.97021
Graham Upside	-52.92
Income Tax	CHF 19.9M
Investing CF	17,996,261
Is Primary Listing	0
Last Earnings Date	2026-02-11
Last Report Date	2025-09-30
Lynch Fair Value	CHF 351
Lynch Upside	21.65
Ma150	306.4
Ma150ch	-5.75%
Ma20	285.2
Ma20ch	1.24%
Net CF	-14,939,817
Next Earnings Date	2026-05-20
Open	296.6
P OCF Ratio	18.83
Payment Date	2025-07-08
Position In Range	10.37
Ppne	580,159,155
Price Date	2026-05-08
Price EBITDA	CHF 13.61
Ptbv Ratio	6.12
Relative Volume	0.84x
Revenue	734,767,868x
Tax By Revenue	2.7x
Tax Rate	9.89%
Tr6m	-6.4%
Volume	1,354
Z Score	9.98

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0QLQ dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.7%

$2.03 annual per share

Payout ratio

+15.5%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+17.4%

3 consecutive years of growth

Total shareholder yield

+0.7%

Next ex-dividend date: 2025-07-04

Performance

LON/0QLQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QLQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.8%

Share of float held by funds and institutions

Insider ownership

+70.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

-0.0%

Negative means the company is buying back shares.

Technical

LON/0QLQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

54.5

Neutral momentum band

Price vs 200-day MA

-12.2%

50/200-day relationship not available

Beta (5Y)

0.74

Less volatile than the market

Sharpe ratio

-0.73

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QLQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QLQ stock rating?

lon/0QLQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QLQ analysis?

The full report lives at /stocks/lon/0QLQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QLQ?

The latest report frames lon/0QLQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QLQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.